Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients

Stéphane De Wit*, Ronan Boulmé, Bénédicte Poll, Jean Claude Schmit, Nathan Clumeck

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)

Abstract

We compared the response to protease inhibitor-containing highly active antiretroviral therapy in 175 HIV-1 treatment-naive patients harbouring subtype B versus non-B. No difference in the proportion of patients with viral loads below 400 copies/ml was observed at month 24. However, there was a significant difference in the median CD4 cell increase at month 24. Whether this is caused by viral or immune factors warrants further investigation.

Original languageEnglish
Pages (from-to)2330-2331
Number of pages2
JournalAIDS
Volume18
Issue number17
DOIs
Publication statusPublished - 19 Nov 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients'. Together they form a unique fingerprint.

Cite this